Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fundraising
Biotech
Aspen adds $115M series C to grow cell therapy ambitions
The raise will power Aspen’s phase 1/2 study of ANPD001, a regenerative cell therapy for Parkinson's disease.
Darren Incorvaia
Nov 20, 2025 7:02am
Fierce Biotech Fundraising Tracker: Aspen, Solve Tx & more
Nov 20, 2025 5:00am
Cornerstone secures $200M to take its surgical robot global
Nov 18, 2025 9:45am
Synchron raises $200M to advance its brain-computer interface
Nov 7, 2025 5:20am
In vivo gene editing biotech blossoms from Jennifer Doudna's lab
Nov 4, 2025 8:00am
Evommune prices IPO amid government shutdown
Oct 30, 2025 12:34pm
